A new prognostic model for myeloma patients relapsing from upfront autologous transplantation based on ISS and PFS1

Br J Haematol. 2019 Apr;185(2):350-353. doi: 10.1111/bjh.15487. Epub 2018 Jul 9.

Authors

Selina J Chavda¹, Paul M Maciocia¹, Pavlina Mesiri², Nicholas Counsell², Jaimal Kothari³, Antonia Bird³, Ciaran Mariner³, Anastasia Chew³, Katherine Clesham³, Sally Moore³, Laura Percy³, Ali Rismani³, Shirley D'Sa³, Neil Rabin³, Rakesh Popat^{1

3}, Kwee Yong^{1

3}

Affiliations

¹ UCL Cancer Institute, London, UK.
² CRUK & UCL Cancer Trials Centre, London, UK.
³ University College London Hospitals NHS Foundation trusts, London, UK.

PMID: 29984833
DOI: 10.1111/bjh.15487

No abstract available

Keywords: multiple myeloma; relapse; stem cell transplantation.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Female
Hematopoietic Stem Cell Transplantation / methods*
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Multiple Myeloma / pathology
Multiple Myeloma / therapy*
Neoplasm Staging
Prognosis
Progression-Free Survival
Recurrence
Retrospective Studies
Salvage Therapy / methods
Transplantation, Autologous